Skip to content

Glaukos GKOS Common Stock

Common Stock at other companies

AbbVie logo
AbbVieABBV
$18M0.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
480M0.0%
Exelixis logo
ExelixisEXEL
400M0.0%

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's common stock?
Glaukos (GKOS) reported common stock of $58K in Q1 2026.
How has Glaukos's common stock changed year-over-year?
Glaukos's common stock increased by 1.8% year-over-year, from $57K to $58K.
What is the long-term trend for Glaukos's common stock?
Over 5 years (2020 to 2025), Glaukos's common stock has grown at a 5.2% compound annual growth rate (CAGR), from $45K to $58K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).